LPL Financial LLC boosted its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 75.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,884 shares of the company's stock after acquiring an additional 3,393 shares during the quarter. LPL Financial LLC's holdings in Addus HomeCare were worth $988,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Summit Place Financial Advisors LLC lifted its holdings in shares of Addus HomeCare by 0.9% in the fourth quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company's stock valued at $1,180,000 after purchasing an additional 80 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in Addus HomeCare by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock valued at $1,340,000 after acquiring an additional 91 shares in the last quarter. Parkside Financial Bank & Trust boosted its holdings in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares during the last quarter. Exchange Traded Concepts LLC grew its stake in shares of Addus HomeCare by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 5,923 shares of the company's stock worth $742,000 after acquiring an additional 150 shares in the last quarter. Finally, Heritage Family Offices LLP raised its holdings in shares of Addus HomeCare by 7.5% in the fourth quarter. Heritage Family Offices LLP now owns 2,274 shares of the company's stock valued at $285,000 after purchasing an additional 159 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have issued reports on ADUS shares. Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Stephens reaffirmed an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie reiterated an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, JMP Securities reiterated a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research note on Tuesday. One analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $139.00.
Get Our Latest Report on ADUS
Addus HomeCare Trading Down 0.0 %
Shares of ADUS stock traded down $0.03 on Friday, hitting $99.51. 23,029 shares of the stock were exchanged, compared to its average volume of 162,670. The firm's 50 day moving average is $98.20 and its two-hundred day moving average is $116.35. Addus HomeCare Co. has a one year low of $88.96 and a one year high of $136.72. The firm has a market capitalization of $1.81 billion, a PE ratio of 22.77, a P/E/G ratio of 1.41 and a beta of 0.93.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. On average, sell-side analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.